CoChat

Genetics in Idiopathic Pulmonary Fibrosis Pathogenesis, Prognosis, and Treatment

Open access
Kaur, Amarpreet, Mathai, Susan K., Schwartz, David A. · 2017 · Frontiers in Medicine
Cited by 129

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

Idiopathic pulmonary fibrosis (IPF), the most common form of idiopathic interstitial pneumonia (IIP), is characterized by irreversible scarring of the lung parenchyma and progressive decline in lung function leading to eventual respiratory failure. The prognosis of IPF is poor with a median survival of three to five years after diagnosis and no curative medical therapies. Though the pathogenesis of IPF is not sufficiently knownnot well understood, there is a increasing growing body of evidence that genetic factors predispose individuals to develop IPFcontribute to disease risk. Recent studies have identified common and rare genetic variants associated with both sporadic and familial forms of pulmonary fibrosis, with at least . Current data suggests that at least one-third of the risk for developing fibrotic IIP and IPF can be explained by common genetic variants. In addition, some common variants have also been associated with distinct clinical phenotypes. The IPF-associated genetic loci discovered to date are associated with IPF are implicated in diverse biological processes, including alveolar stability, host defense, cell-cell barrier function, and cell senescence. In addition, some common variants have also been associated with distinct clinical phenotypes. Identification of gene variants associated with IPF and with IPF-associated mortalityBetter understanding of how genetic variation plays a role in disease risk and phenotype could identify potential therapeutic targets and inform clinical decision-making. Future In addition, clinical studies should be designed controlling for the genetic backgrounds of subjects, since disease phenotype and clinical outcomes and therapeutic responses may differ by genotype. Further understanding of these differences will allow the development of a personalized approaches to the IPF management.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fmed.2017.00154

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Cited by

See all 129

Metadata

Authors
Kaur, A., Mathai, S. K., & Schwartz, D. A.
Venue
Frontiers in Medicine
Published
2017-09-25
Volume
4
Pages
154-154
ISSN
2296-858X (ISSN-L)
OpenAlex
W2757116276
Cited by
129
References
23
FWCI
10.93
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genetics in Idiopathic Pulmonary Fibrosis Pathogenesis, Prognosis, and Treatment. https://app.cochat.ai/papers/10.3389/fmed.2017.00154
The paper
Kaur, A., Mathai, S. K., & Schwartz, D. A. (2017). Genetics in Idiopathic Pulmonary Fibrosis Pathogenesis, Prognosis, and Treatment. Frontiers in Medicine. https://doi.org/10.3389/fmed.2017.00154

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.